Additional information
| Active substance | Albendazole |
|---|---|
| Chemical name | (3ОІ)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate |
| Side effects | Hypertension, hypokalemia, edema, hepatotoxicity, hot flushes, joint swelling or discomfort |
| Effects | Reduces androgen production by inhibiting CYP17, a critical enzyme in testosterone synthesis |
| Dosage (sports) | Not applicable (not used in sports) |
| Dosage (medical) | 1,000 mg once daily in combination with prednisone 5 mg twice daily |
| Half-life | 12 hours |
| Main action | Androgen biosynthesis inhibitor |
| Substance class | Steroidal antiandrogen |
| Formula | C26H33NO2 |
| Storage conditions | Store at controlled room temperature, 20В°C to 25В°C (68В°F to 77В°F) |
| Trade name | Zytiga |
| Blood pressure | Can increase blood pressure |
| Also known as | CB7630 |
| Strength | 400mg |
| Lab Test | Monitoring of liver enzymes and serum potassium levels |
| Hepatotoxicity | Moderate risk |
| Water Retention | Yes |
| Use in sports | None (not used for performance enhancement) |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
Reviews
There are no reviews yet.